Fingerprint
Dive into the research topics of 'Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
Kensei Tobinai, Takashi Watanabe, Michinori Ogura, Yasuo Morishima, Tomomitsu Hotta, Kenichi Ishizawa, Kuniaki Itoh, Shin Ichiro Okamoto, Masafumi Taniwaki, Norifumi Tsukamoto, Hirokazu Okumura, Takashi Terauchi, Shigeru Nawano, Masaki Matsusako, Yoshihiro Matsuno, Shigeo Nakamura, Shigeo Mori, Yasuo Ohashi, Masaki Hayashi, Keigo Endo
Research output: Contribution to journal › Article › peer-review
29
Citations
(Scopus)